Literature DB >> 25981172

Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.

Imke Jenniches1, Svenja Ternes1, Onder Albayram1, David M Otte1, Karsten Bach1, Laura Bindila2, Kerstin Michel1, Beat Lutz2, Andras Bilkei-Gorzo2, Andreas Zimmer3.   

Abstract

BACKGROUND: Disruption of the endocannabinoid system through pharmacological or genetic invalidation of cannabinoid CB1 receptors has been linked to depression in humans and depression-like behaviors in mice. The two main endogenous cannabinoids, anandamide and 2-arachidonoyl glycerol (2-AG), are produced on demand from phospholipids. The pathways and enzymes involved in endocannabinoid biosynthesis thus play a major role in regulating the activity of this system. This study investigates the role of the main 2-AG producing enzyme diacylglycerol lipase α (DAGL-α).
METHODS: We generated and used knockout mice lacking DAGL-α (Dagla(-/-)) to assess the behavioral consequences of reduced endocannabinoid levels in the brain. We performed different behavior tests to determine anxiety- and depression-related behavioral changes in Dagla(-/-) mice. We also analyzed expression of genes related to the endocannabinoid system via real-time polymerase chain reaction and used the mitotic marker 5-bromo-2'-deoxyuridine to analyze adult neurogenesis.
RESULTS: Dagla(-/-) animals show an 80% reduction of brain 2-AG levels but also a reduction in cortical and amygdalar anandamide. The behavioral changes induced by Dagla deletion include a reduced exploration of the central area of the open field, a maternal neglect behavior, a fear extinction deficit, increased behavioral despair, increased anxiety-related behaviors in the light/dark box, and reduced hippocampal neurogenesis. Some of these behavioral changes resemble those observed in animals lacking the CB1 receptor.
CONCLUSIONS: Our findings demonstrate that the deletion of Dagla adversely affects the emotional state of animals and results in enhanced anxiety, stress, and fear responses.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Cannabinoids; Dagla; Depression; Fear extinction; Stress

Mesh:

Substances:

Year:  2015        PMID: 25981172     DOI: 10.1016/j.biopsych.2015.03.033

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  59 in total

1.  Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety.

Authors:  Maria Morena; Robert J Aukema; Kira D Leitl; Asim J Rashid; Haley A Vecchiarelli; Sheena A Josselyn; Matthew N Hill
Journal:  J Neurosci       Date:  2018-12-20       Impact factor: 6.167

2.  Diacylglycerol Lipase-β Is Required for TNF-α Response but Not CD8+ T Cell Priming Capacity of Dendritic Cells.

Authors:  Myungsun Shin; Andrew Buckner; Jessica Prince; Timothy N J Bullock; Ku-Lung Hsu
Journal:  Cell Chem Biol       Date:  2019-05-16       Impact factor: 8.116

3.  Diacylglycerol Lipase-Alpha Regulates Hippocampal-Dependent Learning and Memory Processes in Mice.

Authors:  Lesley D Schurman; Moriah C Carper; Lauren V Moncayo; Daisuke Ogasawara; Karen Richardson; Laikang Yu; Xiaojie Liu; Justin L Poklis; Qing-Song Liu; Benjamin F Cravatt; Aron H Lichtman
Journal:  J Neurosci       Date:  2019-05-24       Impact factor: 6.167

Review 4.  Aging circadian rhythms and cannabinoids.

Authors:  Erik L Hodges; Nicole M Ashpole
Journal:  Neurobiol Aging       Date:  2019-03-25       Impact factor: 4.673

Review 5.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

6.  Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

Authors:  Gaurav Bedse; Nolan D Hartley; Emily Neale; Andrew D Gaulden; Toni A Patrick; Philip J Kingsley; Md Jashim Uddin; Niels Plath; Lawrence J Marnett; Sachin Patel
Journal:  Biol Psychiatry       Date:  2017-03-15       Impact factor: 13.382

7.  Endocannabinoids and Stress Resilience: Is Deficiency Sufficient to Promote Vulnerability?

Authors:  Matthew N Hill; Francis S Lee
Journal:  Biol Psychiatry       Date:  2016-05-15       Impact factor: 13.382

8.  Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus.

Authors:  A Vanessa Stempel; Alexander Stumpf; Hai-Ying Zhang; Tuğba Özdoğan; Ulrike Pannasch; Anne-Kathrin Theis; David-Marian Otte; Alexandra Wojtalla; Ildikó Rácz; Alexey Ponomarenko; Zheng-Xiong Xi; Andreas Zimmer; Dietmar Schmitz
Journal:  Neuron       Date:  2016-04-28       Impact factor: 17.173

Review 9.  2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

Authors:  Gaurav Bedse; Mathew N Hill; Sachin Patel
Journal:  Biol Psychiatry       Date:  2020-03-17       Impact factor: 13.382

Review 10.  Developmental regulation of fear learning and anxiety behavior by endocannabinoids.

Authors:  T T-Y Lee; M N Hill; F S Lee
Journal:  Genes Brain Behav       Date:  2015-11-05       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.